Compounds > n(6)-carboxymethyllysine
Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Fatty Liver

n(6)-carboxymethyllysine has been researched along with Fatty Liver in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Cho, KH; Del Carmen Dominguez-Horta, M; Kim, JE; Martinez-Donato, G; Na, HJ; Nam, HS1
Aragno, M; Boccuzzi, G; Collino, M; Mastrocola, R; Medana, C; Nigro, D; Rogazzo, M1
Andrades, ME; Bortolin, RC; Dal-Pizzol, F; Lorenzi, R; Moreira, JC; Nagai, R1
Bloemen, JG; Buurman, WA; Dejong, CH; Driessen, A; Gaens, KH; Greve, JW; Hofker, MH; Niessen, PM; Rensen, SS; Schalkwijk, CG; Stehouwer, CD; Wolfs, MG1
Alscher, D; Brenner, S; Butscheid, M; Frischmann, M; Klotz, U; Mürdter, T; Niwa, T; Pischetsrieder, M; Schäfer, C1

Other Studies

5 other study(ies) available for n(6)-carboxymethyllysine and Fatty Liver

ArticleYear
CIGB-258 Exerts Potent Anti-Inflammatory Activity against Carboxymethyllysine-Induced Acute Inflammation in Hyperlipidemic Zebrafish via the Protection of Apolipoprotein A-I.
    International journal of molecular sciences, 2023, Apr-11, Volume: 24, Issue:8

    Topics: Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Fatty Liver; Inflammation; Interleukin-6; Lipoproteins, HDL; Zebrafish

2023
Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2013, Sep-15, Volume: 305, Issue:6

    Topics: Animals; Drinking; Fatty Liver; Fructose; Glucose; Glucose Intolerance; Glycation End Products, Advanced; Hypoglycemia; Intracellular Signaling Peptides and Proteins; Lipids; Liver; Lysine; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Triglycerides

2013
Oxidative damage in the liver of rats treated with glycolaldehyde.
    International journal of toxicology, 2011, Volume: 30, Issue:2

    Topics: Acetaldehyde; Animals; Catalase; Fatty Liver; Glycation End Products, Advanced; Injections, Intravenous; Lactoylglutathione Lyase; Lipid Peroxidation; Liver; Liver Cirrhosis; Lysine; Male; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances

2011
Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.
    Journal of hepatology, 2012, Volume: 56, Issue:3

    Topics: Aged; Biomarkers; Biopsy; Cytokines; Enzyme Inhibitors; Fatty Liver; Female; Gene Expression; Guanidines; Hep G2 Cells; Hepatocytes; Humans; In Vitro Techniques; Liver; Lysine; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Pyridoxamine; Vitamin B Complex

2012
Unchanged serum levels of advanced glycation endproducts in patients with liver disease.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Fatty Liver; Female; Glycation End Products, Advanced; Hepatitis C; Humans; Imidazoles; Lysine; Male; Middle Aged; Renal Insufficiency

2007